{
    "id": "wrong_mix_range_leader_00045_0",
    "rank": 61,
    "data": {
        "url": "https://web2.augusta.edu/mcg/psychiatry/research/publications.php",
        "read_more_link": "",
        "language": "en",
        "title": "Publications by Faculty",
        "top_image": "https://web2.augusta.edu/favicon.ico",
        "meta_img": "https://web2.augusta.edu/favicon.ico",
        "images": [
            "https://web2.augusta.edu/images/au-logo.png",
            "https://web2.augusta.edu/images/au-shield.png",
            "https://web2.augusta.edu/images/au-shield.svg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": "2023-02-06T00:00:00",
        "summary": "",
        "meta_description": "Publications by Psychiatry Faculty",
        "meta_lang": "en",
        "meta_favicon": "/favicon.ico",
        "meta_site_name": "Publications by Faculty",
        "canonical_link": "https://www.augusta.edu/colleges/medicine/psychiatry/research/publications.php",
        "text": "McCall WV, Lisanby SH, Rosenquist PB, Dooley M, Husain MM, Knapp RG, Petrides G, Rudorfer MV, Young RC, McClintock SM, Mueller M, Prudic J, Greenberg RM, Weiner RD, Bailine SH, Riley MA, McCloud L, Kellner CH and the CORE/PRIDE Workgroup. Effects of a course of right unilateral ultrabrief pulse electroconvulsive therapy combined with venlafaxine on insomnia symptoms in elderly depressed patients. J Clin Psychiatry 2018;79(2):78-84\n\ndoi: 10.4088/JCP.16m11089. PMID 28742292\n\nMcCall WV, Lisanby SH, Rosenquist PB, Dooley M, Husain MM, Knapp RG, Petrides G, Rudorfer MV, Young RC, McClintock SM, Mueller M, Prudic J, Greenberg RM, Weiner RD, Bailine SH, Youssef NA, McCloud L, Kellner CH and the CORE/PRIDE Workgroup. Effects of continuation electroconvulsive therapy on quality of life in elderly depressed patients: a randomized controlled trial. Journal of Psychiatric Research 2018;97:65-69\n\ndoi: 10.1016/j.jpsychires.2017.11.001\n\nRumble ME, Dickson D, McCall WV, Krystal AD, Case D, Rosenquist PB, Benca RM. The relationship of person-specific eveningness chronotype, greater seasonality, and less rhythmicity to suicidal behavior: a literature review. Journal of Affective Disorders 2018;227:721-730\n\nLundeen J, McCall WV, Krystal A, Looney S. Validating functional data analysis measures from 24-hour actigraphy data. Biological Rhythm Research 2018;49:797-810\n\nRezaie L, Fobian AD, McCall WV, Khazaie H. Paradoxical insomnia and subjective-objective sleep discrepancy: a review. Sleep Medicine Reviews 2018;40:196-202\n\nVarshney SU, Varshney J, Tampi R, McCall WV, Varshney U. AlzaTV: a non-pharmacologic intervention to manage behavioral and psychological symptoms in nursing homes dementia patients. Annals of Clinical Psychiatry 2018;30 (2): 122-132\n\nMcCall WV, Letton A, Lundeen JS, Case D, Cidral-Filho FJ. The effects of far-infrared emitting sheets on sleep. Research Journal of Textile and Apparel 2018; 22(3): 247-259 https://www.emeraldinsight.com/doi/full/10.1108/RJTA-02-2018-0008\n\nMiller BJ, Parker CB, Rapaport MH, Buckley PF, McCall WV. Insomnia and suicidal ideation in non-affective psychosis. Sleep 2019; 42 (2) Feb 2019\n\ndoi: 10.1093/sleep/zsy215 PMID: 30407600\n\nRosenquist PB, Youssef NA, Surya S, McCall WV. When all else fails – the use of electroconvulsive therapy for conditions other than major depressive episode. Psychiatric Clinics of North America 2018;41: 355-371\n\nhttps://doi.org/10.1016/j.psc.2018.04.002\n\nMcCall WV, Pillai A, Case D, McCloud L, Nolla T, Branch F, Youssef NA, Moraczewski J, Tauhidul L, Pandya CD, Rosenquist PB. A pilot, randomized clinical trial of bedtime doses of prazosin versus placebo in suicidal posttraumatic stress disorder patients with nightmares. Journal of Clinical Psychopharmacology 2018;38:618-621\n\ndoi 10.1097/JCP.0000000000000968\n\nHeboyan V, Stevens S, McCall WV. Effects of seasonality and daylight savings time on emergency department visits for mental health disorders. Am J Emergency Medicine.\n\ndoi: 10.1016/j.ajem.2018.10.056\n\nEpub https://doi.org/10.1016/j.ajem.2018.10.056\n\nSurya S, Bishnoi R, Rosenquist PB, McCall WV. Uses of electroconvulsive therapy in conditions other than major depressive episode. Psychiatric Annals 2019;49(4):157-163 https://doi.org/10.3928/00485713-20190314-02\n\nLundeen J, McCall WV, Looney S. Dealing with methodological issues in the functional data analysis of actigraphy data. J Biom Biostat 2019; 10:1\n\ndoi: 10.4172/2155-6180.1000429\n\nYoussef NA, Ravilla D, Patel, Yassa M, Sadek R, Zhang LF, McCloud L, McCall WV, Rosenquist PB. Magnitude of reduction & speed of remission of suicidality for low amplitude seizure therapy (LAP-ST) compared to standard right unilateral ECT: a pilot double-blinded randomized clinical trial. Brain Sciences 2019;9 (5):99.\n\ndoi:10.3390/brainsci9050099\n\nMartinez A, Parker CB, Spearman EV, Rosenquist PB, McCall WV. Globus pharyngeus: etiology, taxonomy, and response to electroconvulsive therapy. Harvard Review of Psychiatry 2019;27 (4):254-259\n\ndoi: 10.1097/HRP.0000000000000229\n\nMoraczewski JA, McCall WV. Emotional content in PTSD nightmares and its relation to other PTSD features: an exploratory study. International Journal of Dream Research 2019; 12 (1) 89-94\n\nhttps://journals.ub.uni-heidelberg.de/index.php/IJoDR/article/view/57959/54234\n\nMcCall WV, Pillai A, Pandya CD, McCloud L, Moraczewski JA, Tauhidul L, Youssef NA, Case D, Rosenquist PB. Bedtime doses of prazosin do not affect daytime salivary amylase markers in PTSD. Heliyon 2019;5: e01709\n\nhttps://doi.org/10.1016/j.heliyon.2019.e01709 PMC 6517516\n\nMcCall WV, Benca RM, Rumble ME, Case D, Rosenquist PB, Krystal AD. Prevalence of obstructive sleep apnea in suicidal patients with Major Depressive Disorder. Journal of Psychiatric Research 2019; 116: 147-150\n\ndoi:10.1016/j.jpsychires.2019.06.01\n\nHaq IU, Snively BM, Sweadner KJ, Suerken CK, Cook JF, Ozelius LJ, Miller C, McCall WV, Whitlow C, Brashear A. Revising Rapid-Onset Dystonia-Parkinsonism indications for ATP1A3 testing. Movement Disorders 2019; 34: 1528-1536\n\nYao Z, McCall WV, Essali N, Wohl E, Parker C, Rosenquist P, Youssef NA. Precision ECT for Major Depressive Disorder: A review of clinical factors, laboratory, and physiologic biomarkers as predictors of response and remission. Personalized Medicine in Psychiatry 2019; 17-18:23-31 https://doi.org/10.1016/j.pmip.2019.07.001\n\nMcCall WV, Benca RM, Rosenquist PB, Youssef NA, McCloud L, Newman JC, Case D, Rumble ME, Szabo ST, Phillips M, Krystal AD. Reducing suicidal ideation through insomnia treatment (REST-IT): a randomized clinical trial. American J Psychiatry 2019: 176: 957-965\n\ndoi: 10.1176/appi.ajp.2019.19030267\n\nNote, this paper was cited by the Editors of the American Journal of Psychiatry as one of the 7 “most interesting and important papers” for 2019 (see AJP 2020;177: 17-19)\n\nNote, this paper was the 4th most talked about paper published in the American Journal of Psychiatry in 2019, with an Altmetric score of ‘320’ as of 2-11-20\n\nLisanby SH, McClintock SM, Alexopolous G, Bailine SH, Bernhardt E, Briggs MC, Cullum CM, Deng Z-D, Dooley M, Geduldig ET, Greenberg RM, Husain MM, Kaliora S, Knapp RG, Latoussakis V, Liebman LS, McCall WV, Mueller M, Petrides G, Prudic J, Rosenquist PB, Rudorfer MV, Sampson S, Teklehaimanot AA, Tobias KG, Weiner RD, Young RC, Kellner CH, on behalf of the CORE/PRIDE Work Group. Neurocognitive effects of combined electroconvulsive therapy (ECT) and venlafaxine in geriatric depression: Phase 1 of the PRIDE study. Am J Ger Psychiatry 2020;28 (3): 304-316\n\nhttps://doi.org/10.1016/j.jagp.2019.10.003 PMID: 31706638\n\nIltis AS, McCall WV, Deria R. Suicidality, Depression and the FDA: Health Inequities and the Ethical Conduct of Research. J Clin Psychiatry 2020;81(2):19m13050 https://doi.org/10.4088/JCP.19m13050\n\nParker CB, McCall WV, Rosenquist PB, Cortese N, Spearman-McCarthy EV. Achieving equity in informed consent: a culturally-informed perspective for the consideration and consent of minority patients for electroconvulsive therapy. Am J Ger Psychiatry 2020;28:1129-1132 Apr 2:S1064-7481(20)30273-6.\n\ndoi: 10.1016/j.jagp.2020.03.009. PMID: 32321667\n\nRumble ME, McCall WV, Dickson DA, Krystal A, Rosenquist PB, Benca RM. An Exploratory Analysis of the Association of Circadian Rhythm Dysregulation and Insomnia With Suicidal Ideation Over the Course of Treatment in Individuals With Depression, Insomnia and Suicidal Ideation. Journal of Clinical Sleep Medicine 2020;16 (8):1311-1319\n\ndoi : 10.5664/jcsm.8508. PMID: 32329435\n\nOstergaard SD, Speed MS, Kellner CH, Mueller M, McClintock SM, Husain MM, Petrides G, McCall WV, Lisanby SH for the CORE/PRIDE workgroup. Electroconvulsive Therapy (ECT) for Moderate-Severity Major Depression among the Elderly: Data from the PRIDE Study. J Affective Disorders 2020; 274:1134-1141\n\nYoussef NA, Dhanani S, Rosenquist PB, McCloud L, McCall WV. Treating PTSD symptoms with low amplitude seizure therapy (LAP-ST) compared to standard right unilateral ECT: a pilot double-blinded randomized clinical trial. J ECT 2020;36:291-295\n\nSackeim HA, Prudic J, Devanand DP, Nobler MS, Haskett RF, Mulsant BH, Rosenquist PB, McCall WV. The Benefits and Costs of Changing Treatment Technique in Electroconvulsive Therapy Due to Insufficient Improvement of a Major Depressive Episode. Brain Stimulation 2020 Jun 22;13(5):1284-1295.\n\ndoi: 10.1016/j.brs.2020.06.016. PMID: 32585354\n\nSahlem GL, McCall WV, Short EB, Rosenquist PB, Fox JB, Youssef NA, Manett AJ, Kerns SE, Dancy MM, McCloud L, George MS, and Sackeim HA. A Two-Site, Open-Label, Non-Randomized Trial Comparing Focal Electrically-Administered Seizure Therapy (FEAST) and Right Unilateral Ultrabrief Pulse Electroconvulsive Therapy (RUL-UBP ECT). Brain Stimulation 2020;13:1416-1425\n\nP Parker CB, McCall WV, Spearman-McCarthy EV, Rosenquist P, Cortese N. Clinician Racial Bias Contributing to Disparities of Electroconvulsive Therapy to Patients of Ethnic and Racial Minorities. Psychiatric Services 2021; 72(6):684-690\n\ndoi: 10.1176/appi.ps.202000142\n\nMcCall WV, Benca RM, Rumble ME, Krystal AD. Blinding and bias in a hypnotic clinical trial. Human Psychopharmacology: Clinical and Experimental 2021;36:e2757. https://doi.org/10.1002/hup.2757\n\nKhazaie H, Zakiei A, McCall WV, Noori K, Rostampour M, Bahmani DS, Brand S. Relationship between sleep problems and self-injury: a systematic review. Behavioral Sleep Medicine 2020;\n\ndoi 10.1080/15402002.2020.1822360\n\nMiller BJ, McEvoy JP, McCall WV. Insomnia, suicidal ideation and suicide attempts in the Clinical Antipsychotic Trials of Intervention Effectiveness. Journal of Clinical Psychiatry 2021;82(3):20m13338\n\nCicek M, McCall WV, Yao Z, Sackeim HA, Rosenquist P, Youssef NA. Is There Evidence That Electric Parameters and Electrode Placement Affect The Cognitive Side Effects of ECT in Patients With Schizophrenia And Schizoaffective Disorder? A Systematic Review.Journal of ECT 2021;37:133-139\n\nMcCall WV, Mensah-Bonsu D, Withers AE, Gibson RW. Short-term Insomnia Disorder in Health Care Workers in an academic medical center before and during COVID-19: rates and predictive factors. Journal of Clinical Sleep Medicine 2021;17 (4): 749-755\n\nMcCall WV, Sareddy S, Youssef NA, Miller BJ, Rosenquist PB. The pupillary light reflex as a point-of-care test for suicide risk: preliminary results. Psychiatry Research 2021;295:113582. https://doi.org/10.1016/j.psychres.2020.113582\n\nMiller BJ, McCall WV, Xia L, Zhang Y, Li W, Yao X, Liu H. Insomnia, suicidal ideation, and psychopathology in Chinese patients with chronic schizophrenia. Progress in Neuropsychopharmacology & Biological Psychiatry. 2021; 111: 110202 https://doi.org/10.1016/j.pnpbp.2020.110202\n\nCasola B, Rosenquist PB, Spearman V, McCall WV, Youssef NA. Safe administration of ECT in a suicidal patients with a space-occupying astrocytoma. J ECT 2021;37 (3):207-208\n\nYoussef NA, McCall WV, Ravilla D, McCloud L, Rosenquist PB. Double-Blinded Randomized Pilot Clinical Trial Comparing Cognitive Side Effects of Standard Ultra-brief Right Unilateral ECT to 0.5A Low Amplitude Seizure Therapy (LAP-ST). Brain Sciences 2020, 10, 979; doi:10.3390/brainsci10120979\n\nYoussef NA, George MS, McCall WV, Sahlem GL, Short B, Kerns S, Dancy M, Cook D, Devries W, Rosenquist PB, Sackeim HA. The Effects of Focal Electrically-Administered Seizure Therapy (FEAST) Compared to Ultrabrief Pulse Right Unilateral Electroconvulsive Therapy on Suicidal Ideation A Two Site Clinical Trial. Journal of ECT 2021;37 (4):256-262.\n\nLisanby SH, McClintock SM, McCall WV, Knapp RG, Cullum CM, Mueller M, Deng Z-D, Teklehaimanot AA, Rudorfer MV, Bernhardt E, Alexopolous G, Bailine SH,Briggs MC, Geduldig BA, Greenberg RM, Husain MH, Kaliora S, Latoussakis V, Liebman LS, Petrides G, Prudic J, Rosenquist PB, Sampson S, Tobias KG, Weiner RD, Young RC, Kellner CH, Prolonging Remission in Depressed Elderly (PRIDE) Work Group. Longitudinal Neurocognitive Effects of Combined Electroconvulsive Therapy (ECT) and Pharmacotherapy in Major Depressive Disorder in Older Adults: Phase 2 of the PRIDE Study. Am J Ger Psychiatry 2022;30 (1):15-28\n\nVarshney S, Varshney U, McCall WV. A Proposal for a novel approach to reduce burdens of care for people with dementia: A Hypothesis. Alzheimer’s and Dementia: The Journal of the Alzheimer’s Association 2022;18:211-221 doi:10.1002/alz.12388\n\nMcCall WV, Porter B, Pate AR, Bolstad CJ, Drapeau CW, Krystal AD, Benca RM, Rumble ME, Nadorff MR. Examining Suicide Assessment Measures for Research Use: Using Item Response Theory to Optimize Psychometric Assessment for Research on Suicidal Ideation in Major Depressive Disorder. Suicide and Life-Threatening Behavior 2021; 51: 1086-1094 https://doi.org/10.1111/sltb.12791\n\nVarshney, U., Singh, N. Dube, S., Varshney, S., McCall, V. (2021.) Mobile Intervention for Alzheimer’s & Other Dementias: Design and Evaluation. International Journal of Interdisciplinary Telecommunication and Networks (IJITN) (In press).\n\nVarshney, U., Singh, N. Dube, S., Varshney, S., McCall, V. (2021) Designing a Mobile Intervention for Alzheimer’s & Other Dementias. Proc. of IEEE Wireless Telecommunication Symposium, 2021\n\nMiller B, McCall W, McEvoy J Lu X-Y. Insomnia and inflammation in Phase 1 of the Clinical Antipsychotics Trials of Intervention Effectiveness Study. Psychiatry Research 2021;305:114195\n\nMiller B, McCall WV. Insomnia and suicide as reported adverse events of second generation antipsychotics and mood stabilizers. J Clinical Sleep Medicine 2022;18:517-522\n\nMcCall WV, Athanasiadi A, Bowie C, Rosenquist PB. Major Depressive Disorder in the older adult associated with globus pharyngeus and weight loss – an indication for ECT. Am J Geriatric Psychiatry 2022;30 (2):235-239\n\ndoi: 10.1016/j.jagp.2021.10.010\n\nMcCall WV, Rosenquist PB, Miller BJ. Development of autonomic nervous system assays as point of care tests to supplement clinical judgement in risk assessment for suicidal behavior: a review. Current Psychiatry Reports 2022; https://doi.org/10.1007/s11920-022-01315-6\n\nBorentain S, Williamson D, Turkoz I, Popova V, McCall WV, Mathews M, Wiegand F. Effect of sleep disturbance on efficacy of esketamine in treatment-resistant depression: findings from randomized controlled trials. Neuropsychiatric Disease and Treatment 2021;17:3459-3470\n\nOnyilo C, McCall WV, Rosenquist P. TMS therapy of MDD improves HRV. Journal of ECT (in press)\n\nXu Y, Su S, McCall WV, Isales C, Sneider H, Wang X. Rest-activity circadian rhythm and impaired glucose tolerance in adults: an analysis of NHANES 2011-2014. BMJ Open Diabetes Research & Care (in press).\n\nIltis AS, Fortier R, Ontjes N, McCall WV. Ethics considerations regarding laws restricting incapacitated patients’ access to ECT. Journal of the American Academy of Psychiatry and the Law. (in press)\n\nXu Y, Su S, McCall WV, Wang X. Blunted Rest-Activity Rhythm is associated with Increased White Blood-Cell-Based Inflammatory Markers in Adults: An Analysis from NHANES 2011-2014. Chronobiology International 2022 2022/06/03;39(6):895-902\n\nDOI 10.1080/07420528.2022.2048663"
    }
}